These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 1707211

  • 1. Striatal dopamine and glutamate release: effects of intranigral injections of substance P.
    Reid MS, Herrera-Marschitz M, Kehr J, Ungerstedt U.
    Acta Physiol Scand; 1990 Dec; 140(4):527-37. PubMed ID: 1707211
    [Abstract] [Full Text] [Related]

  • 2. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
    Reid MS, O'Connor WT, Herrera-Marschitz M, Ungerstedt U.
    Brain Res; 1990 Jun 11; 519(1-2):255-60. PubMed ID: 1975763
    [Abstract] [Full Text] [Related]

  • 3. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
    Reid MS, Herrera-Marschitz M, Hökfelt T, Ohlin M, Valentino KL, Ungerstedt U.
    Neuroscience; 1990 Jun 11; 36(3):643-58. PubMed ID: 1700329
    [Abstract] [Full Text] [Related]

  • 4. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
    Reid MS, Herrera-Marschitz M, Hökfelt T, Lindefors N, Persson H, Ungerstedt U.
    Exp Brain Res; 1990 Jun 11; 82(2):293-303. PubMed ID: 1704847
    [Abstract] [Full Text] [Related]

  • 5. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ, Marshall JF.
    Synapse; 2000 Jun 01; 36(3):194-204. PubMed ID: 10819899
    [Abstract] [Full Text] [Related]

  • 6. Intranigral substance P stimulation of striatal dopamine release is inhibited by spantide II: a new tachykinin antagonist without apparent neurotoxicity.
    Reid MS, Hökfelt T, Herrera-Marschitz M, Håkanson R, Feng DM, Folkers K, Goldstein M, Ungerstedt U.
    Brain Res; 1990 Nov 05; 532(1-2):175-81. PubMed ID: 1704289
    [Abstract] [Full Text] [Related]

  • 7. Effects of intranigral substance P and neurokinin A on striatal dopamine release--II. Interactions with bicuculline and naloxone.
    Reid MS, Herrera-Marschitz M, Ungerstedt U.
    Neuroscience; 1990 Nov 05; 36(3):659-67. PubMed ID: 1700330
    [Abstract] [Full Text] [Related]

  • 8. Intranigral substance P modulation of striatal dopamine: interaction with N-terminal and C-terminal substance P fragments.
    Reid MS, Herrera-Marschitz M, Terenius L, Ungerstedt U.
    Brain Res; 1990 Sep 03; 526(2):228-34. PubMed ID: 1701682
    [Abstract] [Full Text] [Related]

  • 9. Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat.
    Ferraro L, O'Connor WT, Beggiato S, Tomasini MC, Fuxe K, Tanganelli S, Antonelli T.
    Eur J Neurosci; 2012 Jan 03; 35(2):207-20. PubMed ID: 22211865
    [Abstract] [Full Text] [Related]

  • 10. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.
    Mela F, Marti M, Bido S, Cenci MA, Morari M.
    Neurobiol Dis; 2012 Jan 03; 45(1):573-82. PubMed ID: 22001605
    [Abstract] [Full Text] [Related]

  • 11. Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P.
    Reid M, Herrera-Marschitz M, Hökfelt T, Terenius L, Ungerstedt U.
    Eur J Pharmacol; 1988 Mar 15; 147(3):411-20. PubMed ID: 2454197
    [Abstract] [Full Text] [Related]

  • 12. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.
    Lindefors N, Brodin E, Tossman U, Segovia J, Ungerstedt U.
    Exp Brain Res; 1989 Mar 15; 74(3):527-34. PubMed ID: 2468514
    [Abstract] [Full Text] [Related]

  • 13. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
    Marti M, Manzalini M, Fantin M, Bianchi C, Della Corte L, Morari M.
    J Neurochem; 2005 Apr 15; 93(1):195-205. PubMed ID: 15773919
    [Abstract] [Full Text] [Related]

  • 14. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.
    Yang J, Hu LF, Liu X, Zhou F, Ding JH, Hu G.
    Life Sci; 2006 Mar 20; 78(17):1940-4. PubMed ID: 16216278
    [Abstract] [Full Text] [Related]

  • 15. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 20; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 16. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
    Calabresi P, Mercuri NB, Sancesario G, Bernardi G.
    Brain; 1993 Apr 20; 116 ( Pt 2)():433-52. PubMed ID: 8096420
    [Abstract] [Full Text] [Related]

  • 17. Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis.
    Herrera-Marschitz M, Christensson-Nylander I, Sharp T, Staines W, Reid M, Hökfelt T, Terenius L, Ungerstedt U.
    Exp Brain Res; 1986 Apr 20; 64(1):193-207. PubMed ID: 2429859
    [Abstract] [Full Text] [Related]

  • 18. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis.
    Globus MY, Busto R, Dietrich WD, Martinez E, Valdes I, Ginsberg MD.
    J Neurochem; 1988 Nov 20; 51(5):1455-64. PubMed ID: 2902196
    [Abstract] [Full Text] [Related]

  • 19. Alpha 2-adrenoceptors are not involved in the regulation of striatal glutamate release: comparison to dopaminergic inhibition.
    Harsing LG, Vizi ES.
    J Neurosci Res; 1991 Mar 20; 28(3):376-81. PubMed ID: 1677428
    [Abstract] [Full Text] [Related]

  • 20. Effects of intranigral substance P and neurokinin A injections on extracellular dopamine levels measured with microdialysis in the striatum and frontoparietal cortex of rats.
    Reid MS, Herrera-Marschitz M, Ungerstedt U.
    J Neurochem; 1991 Sep 20; 57(3):970-4. PubMed ID: 1713616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.